SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950162-08-000091
Filing Date
2008-02-13
Accepted
2008-02-13 15:02:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCICLONE PHARMACEUTICALS/SIGMA TAU FIN. SCHEDULE 13G/A NO.5 scisigmafin13gano5_021308.htm SC 13G/A 91273
  Complete submission text file 0000950162-08-000091.txt   93074
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43408 | Film No.: 08603982
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13G/A